Lifenity Wellness International Limited 504 Pentagon P3, Magarpata Cy Hadapsar, Pune - 411028 LIFENITY Email - nogentywetness.com WELLNESS Website vw Meniyvalias PATIENT ID + 1.C000180022301 PATIENT NAME —; DEEPAK CHOUDHARY AGEISEX 23 YEAR /Male PATIENT ID NO; Po957025 Passpon) DoB Na REF. BY 2 SELF SAMPLE COLL.DATE : 09052021 01:56AM CUSTOMER NAME; MUMBAIINTERNATIONAL AIRPORT(DEPARTURE) REG. DATE/TIME: 0505202 NATIONALITY INDIAN REPORT DATE/TIME REAL TIME ITATIVE RT PCR DI TON OF SA‘ Investigation Result CT VALUE FOR CONFIRMATORY GENE NA SAR-CoV-2 (COVID 19) Not Detected SPECIMEN : NASOPHARYNGEAL AND OROPHARYNGEAL SWAB METHOD = Real time Reverse Transcriptase PCR using commercaly available ICMR approved kit (Taqman probe based) KIT SPECIFICATION : Meti COVID-19 One Step RT-PCR kit CLINICAL INTERPRETATION : The given test dotecs RNA of SARS-CoV-2 vius in submited clinical sample, where in ORFIab & N gene isthe target for detecion REMARKS: 1) A detected results considered as positive andis indicative ofthe presence of SARS-CoV-2 infection. Cnicalcorelation with patient history ‘and other dlagnostic information's nessa to determine patent infection status 2) Positive results do not rule out bacteria iefection or co-nfecion with other viruses, The agent detected may not be the definite cause of disease 53) not detected result means that SARS-CoV'2 RNA was nol present in the specimen above the limit of detection, However improper sample Calecion, handling. storage and tansportation may result in false negative result. The report represents only the specimen received in laboratory. LIMITATIONS 1) Presence of PCR inhibitor may interfere with PCR amplification 2) Negative resus do rot rule out poss bity of SARS-CoV-2 infecion and should not be used as the sole bass for patient management ‘decisions. Presence of inhibitors, mutatons and insufcient organism RNA can influence the result 43) Positive result does nt disingush between wable and nonvabie vius. 4) Viral load'shedksng may afer atthe beginning and towards the end of infection in an individual, thus repeat testing done on diferent days may ‘show diferent resus, '5) The testis qualitative assay and isnot recommended by ICMR to quanti viral load due to several technical issues, 68} Vanous ICMR approved kts may have diflerences in test Sensitivity, speciily and cut of valves for PCR cyeles, thus may resutin diference of results 7) Research studies are continually updating the knowledge about SARS -CoV 2 and should be considered while review ofthis report, ICMR REGISTRATION NO; LIFWLLILMMH NABL Certicate ; MC-T37 Please scan this QR Code for Validation ~End Of Report Sean this QR Code with FACTIVE™ App Fact & Repo verity FACTIVE™ Dr. Manjeet S Mebta Dr. Disha Sharma Pro Mo Consultant Molecular Biologist Consultant Microbiclogist Pcs at ry Wear i 121 FLOOR 9 WING TRADE WORLD KAIALANILSLOWER PAREL, MBA Parte